Next Article in Journal
Clinical Utility of Repeated Urimal Test of Articulation and Phonation for Patients with Childhood Apraxia of Speech
Previous Article in Journal
Prognostic Risk Factors for Severe Outcome in the Acute Phase of Neonatal Hypoxic-Ischemic Encephalopathy: A Prospective Cohort Study
Systematic Review

Kidney Tubular Damage Secondary to Deferasirox: Systematic Literature Review

Department of Pediatrics, Pediatric Institute of Southern Switzerland, Ospedale San Giovanni, 6500 Bellinzona, Switzerland
Pediatric Unit, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, 20122 Milan, Italy
Pediatric Cardiology Unit, Department of Pediatrics, Centre Hospitalier Universitaire Vaudois, and University of Lausanne, 1010 Lausanne, Switzerland
Heart Failure and Transplantation, Department of Pediatric Cardiology, Great Ormond Street Hospital, London WC1N 3JH, UK
Department of Clinical Sciences and Community Health, Università degli Studi di Milano, 20122 Milan, Italy
Author to whom correspondence should be addressed.
Academic Editor: Pierluigi Marzuillo
Children 2021, 8(12), 1104;
Received: 7 October 2021 / Revised: 26 November 2021 / Accepted: 26 November 2021 / Published: 1 December 2021
Deferasirox is a first-line therapy for iron overload that can sometimes cause kidney damage. To better define the pattern of tubular damage, a systematic literature review was conducted on the United States National Library of Medicine, Excerpta Medica, and Web of Science databases. Twenty-three reports describing 57 individual cases could be included. The majority (n = 35) of the 57 patients were ≤18 years of age and affected by thalassemia (n = 46). Abnormal urinary findings were noted in 54, electrolyte or acid–base abnormalities in 46, and acute kidney injury in 9 patients. Latent tubular damage was diagnosed in 11 (19%), overt kidney tubular damage in 37 (65%), and an acute kidney injury in the remaining nine (16%) patients. Out of the 117 acid–base and electrolyte disorders reported in 48 patients, normal-gap metabolic acidosis and hypophosphatemia were the most frequent. Further abnormalities were, in decreasing order of frequency, hypokalemia, hypouricemia, hypocalcemia, and hyponatremia. Out of the 81 abnormal urinary findings, renal glucosuria was the most frequent, followed by tubular proteinuria, total proteinuria, and aminoaciduria. In conclusion, a proximal tubulopathy pattern may be observed on treatment with deferasirox. Since deferasirox-associated kidney damage is dose-dependent, physicians should prescribe the lowest efficacious dose. View Full-Text
Keywords: deferasirox; kidney tubular damage; chelator; iron overload; transfusion deferasirox; kidney tubular damage; chelator; iron overload; transfusion
Show Figures

Figure 1

MDPI and ACS Style

Scoglio, M.; Cappellini, M.D.; D’Angelo, E.; Bianchetti, M.G.; Lava, S.A.G.; Agostoni, C.; Milani, G.P. Kidney Tubular Damage Secondary to Deferasirox: Systematic Literature Review. Children 2021, 8, 1104.

AMA Style

Scoglio M, Cappellini MD, D’Angelo E, Bianchetti MG, Lava SAG, Agostoni C, Milani GP. Kidney Tubular Damage Secondary to Deferasirox: Systematic Literature Review. Children. 2021; 8(12):1104.

Chicago/Turabian Style

Scoglio, Martin, Maria D. Cappellini, Emanuela D’Angelo, Mario G. Bianchetti, Sebastiano A.G. Lava, Carlo Agostoni, and Gregorio P. Milani. 2021. "Kidney Tubular Damage Secondary to Deferasirox: Systematic Literature Review" Children 8, no. 12: 1104.

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

Back to TopTop